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Banff 05 eliminated chronic allograft nephropathy and
divided anti-allograft lesions into antibody-mediated
rejection (AMR) (acute and chronic) and T-cell-mediated
rejection (CMR) (acute and chronic). Transplant
glomerulopathy (TG) became a criterion for the diagnosis
of chronic AMR, along with peritubular capillary (PTC)
basement membrane multilayering and positive C4d
staining. This nosology is consistent with the increasing
presumption that TG is largely a manifestation of AMR.
We report here our experience with TG in patients
screened for donor specific antibodies (DSAs).
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Figure 1A-C: Electron micrographs of 3 patients with transplant glomerulopathy.

The 50 cases were retrieved from the Surgical Pathology
database of Thomas Jefferson University Hospital. All
biopsies were obtained for cause and examined by both
light and electron microscopy (Figure 1). C4d staining was
by immunofluorescence microscopy until 12/2008 and
thereafter by immunohistochemistry. DSAa were detected
by Luminex Lab Screen.

Table 1: DSA Data Analysis
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The mean age of the 50 patients was 50.5 years (Table 1).
Eleven patients were retransplants. The mean donor age was
39.3 years (31 deceased and 17 living). DSAs were absent in
24 of the 50 patients and detected in 26. 23 patients were
completely negative and 1 patient had a weak antibody
titer of 1600 MFI. The mean time to biopsy in those with DSAs
was 62 months and 74 months in those without. The mean
creatinine (mg/dL) at biopsy in the DSA group was 3.0 + 1.2
(SD) and 2.8 + 1.4 in the negative group. The mean proteinuria
at biopsy in the same groups was 1.7 g + 1.6 and 3.6 + 3.9,
respectively. None of the DSA-negative patients experienced
acute CMR, whereas 10 patients with DSAs did. Two of the
26 DSA-positive patients had acute AMR, whereas none of
the 24 DSA-negative patients did. None of the DSA-negative
patients had C4d staining of PTC, whereas 7 of the DSApositive patients did. Fifteen of the DSA-negative and 21
of the positive patients showed PTC basement membrane
multilayering (Figure 2).
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Figure 2: Prominent multilayering of the basement
membrane of a peritubular capillary.

Half of our 50 patients with TG documented by EM had
no DSAs or positive C4d staining in PTCs. Almost 70%
of the patients evidenced PTC basement membrane
multilayering. These patients were all diagnosed with
chronic active CMR independently of the presence of
TG. Cellular rejection mechanisms are likely the cause
of the TG in this group. Patients with TG and DSAs are
at greater risk for episodes of acute AMR and CMR.
C4d staining of PTCs was evident in less than 40%
and in the glomeruli in less than half. Interestingly, 25
of the 26 DSA+ patients were independently diagnosed
with chronic active CMR.

